ClinicalTrials.gg
Active, not recruitingNCT05618158Updated Oct 19, 2026

Cancer Prevention for Young Rural Adults

An interventional study of 4 Corners Rural Health Cancer Prevention in Cancer, sponsored by Klein Buendel, Inc.. Active, not recruiting at 5 sites in United States. Open to participants aged 18 Years to 26 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Klein Buendel, Inc. · Not applicable, Interventional, and Prevention

Updated Oct 19, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
1,796
Allocation
Not applicable
Ages
18 Years to 26 Years
Sex
All
01

Study summary

Young adults aged 18-26 engage in a number of behaviors that increase their risk of developing cancer later in life including sedentary lifestyles, unhealthy eating, nicotine produce us, heavy drinking of alcohol, increased UV exposure, and incomplete uptake of HPV vaccination. A multi-risk factor campaign will be developed to reduce these cancer risk behaviors and delivered to young adults over social media, a popular channel that can reach nearly all young adults. The campaign will be evaluated for effectiveness in a rigorous randomized trial with measures of moderate to vigorous physical activity, healthy eating patterns, nicotine product use, alcohol intake, sunburn prevalence, and HPV vaccination uptake.

Read the detailed description

Several risk factors are prevalent during early adulthood that can lead to cancer later in life. Emerging adults (EAs) aged 18-26 residing in rural areas of the United States engage in many cancer risk behaviors, especially sedentary lifestyles, poor eating patterns, nicotine product use, excess alcohol intake, infrequent sun protection, and inadequate uptake of the HPV vaccine. This application responds to RFA-CA-20-051, "Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations." The goal is to improve cancer risk behavioral factors among diverse EAs aged 18-26 living in rural counties in the Four Corners states, a unique, underserved region, using a social media campaign designed with community advisors. EAs, including in rural communities, are heavy consumers of online content, especially over social media, and social media provide responsive, engaging, and low-cost platforms for distributing cancer prevention information with high dissemination potential. But, social media also circulate inaccurate, misleading, and harmful information. The specific aims of this research are to: 1) Develop a social media intervention for diverse EAs in rural communities via a community-engaged process that combines expert advice, user-generated content, and online instruction to communicate about behavioral cancer risks, cancer misinformation, counter marketing, digital and media literacy, and family communication; 2) evaluate the effect of a theory-based social media intervention on moderate to vigorous physical activity (MVPA), healthy eating patterns, nicotine product use, alcohol intake, sunburn prevalence, and HPV vaccination with the diverse population of EAs aged 18-26 in rural counties in AZ, CO, NM, and UT (Four Corners states) recruited from Qualtrics' survey panel and enrolled in a pragmatic randomized trial using a stepped-wedge design in which individual EAs will be randomized to 1 of 4 cohorts and receive the social media feed for varying durations in separate Facebook private groups; 3) test if improvements in EAs' cancer risk knowledge and beliefs, digital and media literacy skills, accurate cancer prevention information, and family communication mediate impact of the social media campaign; and 4) explore whether the impact of the social media campaign differs according to: a) level of EAs' engagement with campaign, b) cancer risk factors, and c) biological sex of the participants (as required by NIH). The research is innovative because it tests a theory-based, multi-risk factor approach to cancer prevention with diverse EAs in rural counties, an under-studied population, in a very popular new media. Social media may reach EAs more than interventions through other community channels (e.g., clinics, schools, and workplaces) and for lower cost in the geographically-dispersed, underserved rural communities in the Mountain West. The overall impact is extremely high because it will aid rural EAs in making informed decisions that reduce cancer risk factors and prevent cancer later in life and help EAs critically evaluate and resist misinformation and marketing that promote cancer risk behaviors.

02

Conditions studied

  • Cancer

Keywords

  • social media
  • cancer prevention
  • nicotine use
  • physical activity
  • nutrition
  • sun protection
  • alcohol use
  • HPV vaccine
  • media literacy
03

In context

Neoplasms

10,818 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.

This study's enrollment of 1,796 is above the median of 60 across 7,703 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Klein Buendel, Inc. is the lead sponsor of 35 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 26 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18-26 years old
  • Resides in a county coded as RUCC 4-9 in Arizona, Colorado, New Mexico, or Utah
  • Able to speak and read English
  • Has regular social media engagement
  • Accepts screening call from study staff
  • Consents to participate

Exclusion criteria

Exclusion Criteria:

  • Participated in community engagement activities
  • Cannot speak and read English
  • Has low or no social media engagement
  • Does not accept a screening call from study staff
  • Does not consent to participate
  • Does not give permission for engagement data to be extracted from Facebook private group
  • If biologically female, currently pregnant
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
1,796 participants (actual)

Study arms

  • Experimental
    4 Corners Rural Cancer Prevention

    Four separate Facebook groups, which provide information via posts within the private groups about cancer risk factors (e.g. reducing alcohol consumption, tobacco use cessation, increasing physical activity), behavioral skills to reduce them, benefits of, social support for, and ways to reduce social/financial costs of cancer prevention, and advice from health care providers to decrease barriers. Posts will seek to improve self- and response-efficacy and perceived risk, and link cancer prevention to personal goals.

    Behavioral: 4 Corners Rural Health Cancer Prevention

Interventions

  • Behavioral4 Corners Rural Health Cancer Prevention

    Participants, aged 18-26, will join a private Facebook group to participate in the intervention. The group is not viewable to the public, including other Facebook users. Content that focuses on cancer prevention behaviors will be posted twice per day for up to 12 months. Each group will be hosted by a moderator who is responsible for managing the intervention goals and participants' engagement.

06

What researchers measure

Primary outcomes

  1. Physical Activity

    Participants will self-report minutes per week of moderate to vigorous physical activity.

    Time frame: Baseline

  2. Physical Activity

    Participants will self-report minutes per week of moderate to vigorous physical activity.

    Time frame: 3 months

  3. Physical Activity

    Participants will self-report minutes per week of moderate to vigorous physical activity.

    Time frame: 12 months

  4. Physical Activity

    Participants will self-report minutes per week of moderate to vigorous physical activity.

    Time frame: 24 months

  5. Diet

    Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.

    Time frame: Baseline

  6. Diet

    Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.

    Time frame: 3 months

  7. Diet

    Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.

    Time frame: 12 months

  8. Diet

    Participants will self-report intake per day of fruits, vegetables, whole grains/fiber, added sugars (from sugar-sweetened beverages), and red/processed meats.

    Time frame: 24 months

  9. Nicotine Product Use

    Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).

    Time frame: Baseline

  10. Nicotine Product Use

    Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).

    Time frame: 3 months

  11. Nicotine Product Use

    Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).

    Time frame: 12 months

  12. Nicotine Product Use

    Participants will self-report tobacco/nicotine use in the past 30 days (every day, some days, not at all).

    Time frame: 24 months

  13. Alcohol Intake

    Participants self-report consumption of number of alcoholic drinks in the past 30 days.

    Time frame: Baseline

  14. Alcohol Intake

    Participants self-report consumption of number of alcoholic drinks in the past 30 days.

    Time frame: 3 months

  15. Alcohol Intake

    Participants self-report consumption of number of alcoholic drinks in the past 30 days.

    Time frame: 12 months

  16. Alcohol Intake

    Participants self-report consumption of number of alcoholic drinks in the past 30 days.

    Time frame: 24 months

  17. Uv Exposure

    Participants will self-report number of sunburns.

    Time frame: Baseline

  18. Uv Exposure

    Participants will self-report number of sunburns.

    Time frame: 3 months

  19. Uv Exposure

    Participants will self-report number of sunburns.

    Time frame: 12 months

  20. Uv Exposure

    Participants will self-report number of sunburns.

    Time frame: 24 months

  21. HPV Vaccination

    Participants will self-report whether or not they have received one or more doses of the HPV vaccine.

    Time frame: Baseline

  22. HPV Vaccination

    Participants will self-report whether or not they have received one or more doses of the HPV vaccine.

    Time frame: 3 months

  23. HPV Vaccination

    Participants will self-report whether or not they have received one or more doses of the HPV vaccine.

    Time frame: 12 months

  24. HPV Vaccination

    Participants will self-report whether or not they have received one or more doses of the HPV vaccine.

    Time frame: 24 months

Secondary outcomes

  1. Physical Activity

    Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.

    Time frame: Baseline

  2. Physical Activity

    Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.

    Time frame: 3 months

  3. Physical Activity

    Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.

    Time frame: 12 months

  4. Physical Activity

    Participants will self-report number of minutes per week engaging in physical activity to determine if they meet the 150 minutes per week recommendation.

    Time frame: 24 months

  5. Diet

    Participants will self-report frequency of eating meals away from home/fast food.

    Time frame: Baseline

  6. Diet

    Participants will self-report frequency of eating meals away from home/fast food.

    Time frame: 3 months

  7. Diet

    Participants will self-report frequency of eating meals away from home/fast food.

    Time frame: 12 months

  8. Diet

    Participants will self-report frequency of eating meals away from home/fast food.

    Time frame: 24 months

  9. Nicotine Product Use

    Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).

    Time frame: Baseline

  10. Nicotine Product Use

    Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).

    Time frame: 3 months

  11. Nicotine Product Use

    Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).

    Time frame: 12 months

  12. Nicotine Product Use

    Participants will self-report tobacco/nicotine use in the past 7 days (every day, some days, not at all).

    Time frame: 24 months

  13. Nicotine Product Use

    Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).

    Time frame: Baseline

  14. Nicotine Product Use

    Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).

    Time frame: 3 months

  15. Nicotine Product Use

    Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).

    Time frame: 12 months

  16. Nicotine Product Use

    Participants will self-report readiness to quit using a 10 point rating scale (1=no thought of quitting; 10=taking action to quit).

    Time frame: 24 months

  17. Alcohol Intake

    Participants will self-report number of times binge drinking in the past 30 days.

    Time frame: Baseline

  18. Alcohol Intake

    Participants will self-report number of times binge drinking in the past 30 days.

    Time frame: 3 months

  19. Alcohol Intake

    Participants will self-report number of times binge drinking in the past 30 days.

    Time frame: 12 months

  20. Alcohol Intake

    Participants will self-report number of times binge drinking in the past 30 days.

    Time frame: 24 months

  21. UV Exposure

    Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.

    Time frame: Baseline

  22. UV Exposure

    Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.

    Time frame: 3 months

  23. UV Exposure

    Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.

    Time frame: 12 months

  24. UV Exposure

    Participants will self-report sun protection behaviors with percent of sun exposure hours using sun protection.

    Time frame: 24 months

  25. HPV Vaccination

    Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.

    Time frame: Baseline

  26. HPV Vaccination

    Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.

    Time frame: 3 months

  27. HPV Vaccination

    Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.

    Time frame: 12 months

  28. HPV Vaccination

    Participants will self-report if they have completed the series of HPV vaccination by receiving 3 doses of the vaccine.

    Time frame: 24 months

07

Study locations

5 sites
08

References and documents

Publications

  • Warner EL, Kinsey A, Walkosz BJ, Berteletti J, Nuss K, Small A, Woodall WG, Kepka D, Taren D, Skiba MB, Guest DD, Blair CK, Gordon JS, Wetter DW, Borrayo EA, Henry KL, Sussman AL, Buller DB. A Web-Based Cancer Prevention Intervention for Rural Emerging Adults: Mixed Methods Development and Pilot-Testing Study. J Med Internet Res. 2026 Jan 8;28:e80803. doi: 10.2196/80803. PubMed 41505184 ↗
  • Buller DB, Sussman AL, Thomson CA, Kepka D, Taren D, Henry KL, Warner EL, Walkosz BJ, Woodall WG, Nuss K, Blair CK, Guest DD, Borrayo EA, Gordon JS, Hatcher J, Wetter DW, Kinsey A, Jones CF, Yung AK, Christini K, Berteletti J, Torres JA, Barraza Perez EY, Small A. #4Corners4Health Social Media Cancer Prevention Campaign for Emerging Adults: Protocol for a Randomized Stepped-Wedge Trial. JMIR Res Protoc. 2024 Feb 22;13:e50392. doi: 10.2196/50392. PubMed 38386396 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Mar 2027, 35 months after the start.

Of 75 industry-sponsored interventional studies with no phase under Neoplasms, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 53. This study's planned 35 months is above that.

Counting every sponsor, half of 2,056 studies reached it within 29 months; a quarter within 13 and three quarters within 52.

Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 19, 2026: start Aug 2024 → Apr 2024, primary completion Dec 2026 → Mar 2027 and completion Mar 2027 → Aug 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2022
First posted
Nov 16, 2022
StartActual
Apr 20, 2024was Aug 2024
Primary completionEst.
Mar 31, 2027was Dec 2026
CompletionEst.
Aug 31, 2027was Mar 2027
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Aug 26, 2024→Apr 20, 2024
Oct 19, 2026
Primary completion
Dec 31, 2026→Mar 31, 2027
Oct 19, 2026
Study completion
Mar 31, 2027→Aug 31, 2027
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    Start date Aug 26, 2024→Apr 20, 2024
    Primary completion Dec 31, 2026→Mar 31, 2027
    Study completion Mar 31, 2027→Aug 31, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05618158
Responsible party
Sponsor
First posted
Nov 16, 2022
Start date
Apr 20, 2024
Primary completion
Mar 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Oct 19, 2026

Study contacts

David Buller, PhD
principal investigator · Klein Buendel, Inc.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion